Code | 2864A | ||||||||||
MA number | 44/0436/12-S | ||||||||||
Product Form: | sol ijf 1x5 ml/500 mg (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 18 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Subcutaneous and intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 28.09.2012 |
Pediatric indication: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Cytarabin Kabi 100 mg/ml_01/2021.doc |
SPC: | SPC_Cytarabin Kabi 100 mg/ml_01/2021.doc |
Safety feature | Yes |
Data update: | 29.05.2018 |